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Abstract
Dual-energy computed tomography (DECT) allows distinguishing between tissues with similar X-ray attenuation but different
atomic numbers. Recent studies demonstrated that this technique has several areas of application in patients with ischemic stroke
and a potential impact on patient management. After endovascular stroke therapy (EST), hyperdense areas can represent either
hemorrhage or contrast staining due to blood-brain barrier disruption, which can be differentiated reliably by DECT. Further
applications are improved visualization of early infarctions, compared to single-energy computed tomography, and prediction of
transformation into infarction or hemorrhage in contrast-enhancing areas. In addition, DECT allows detection and evaluation of
the material composition of intra-arterial clots after EST. This review summarizes the clinical state-of-the-art of DECT in patients
with stroke, and features some prospects for future developments.
Key points
• Dual-energy computed tomography (DECT) allows differentiation between tissues with similar X-ray attenuation but different
atomic numbers.
• DECT has several areas of application in patients with ischemic stroke and a potential impact on patient management.
• Prospects for future developments in DECT may improve treatment decision-making.
Keywords Stroke . Brain ischemia . Tomography, X-ray computed . Hemorrhage . Thrombosis
Abbreviations






DECT Dual-energy computed tomography
DLCT Dual-layer detector CT
D W I -
MRI
Diffusion-weighted magnetic resonance imaging
EID Energy-integrating detectors








1 Department of Neuroradiology, Medical University of Innsbruck,
Innsbruck, Austria
2 Neuroimaging Research Core Facility, Medical University of
Innsbruck, Innsbruck, Austria
3 NMR Research Unit, Queens Square MS Centre, Department of
Neuroinflammation, UCL Queen Square Institute of Neurology,
Faculty of Brain Science, University College London, London, UK
4 Department of Biomedical Imaging and Image Guided Therapy,
Medical University of Vienna, Vienna, Austria
5 Institute of Neurology, University College London, London, UK
6 Department of Radiology, University of Cambridge, Cambridge, UK
7 Department of Radiology, Medical University of Innsbruck,
Innsbruck, Austria
8 Department of Neurology, Medical University of Innsbruck,
Innsbruck, Austria
https://doi.org/10.1007/s00330-020-07543-9
/ Published online: 14 December 2020
European Radiology (2021) 31:4138–4147




RBC Red blood cell
SECT Single-energy computed tomography
TICI Thrombolysis in cerebral infarction




The benefit of dual-energy computed tomography (DECT)
compared to single-energy computed tomography (SECT) in
acute ischemic stroke has been documented in several studies
[1–5]. DECT reliably differentiates between tissues with sim-
ilar X-ray attenuation but different compositions, with regard
to atomic numbers [6], and further extrapolates virtual mono-
chromatic series of a certain tube voltage [7].
Initially, DECT was designed for coronary imaging, as it
provides not only visualization of stenosis but also high accu-
racy for the detection and characterization of coronary plaques
[8–10].
For neuroradiological applications [6, 7, 11–17], four ma-
jor different DECT techniques are available: (1) dual-source
X-ray tubes with different tube voltages, 80–100 kV and
140 kV, performing simultaneously (Siemens); (2) single-
source rapid voltage switching between two tube voltages
(GE); (3) a single-source split beam, where the X-ray beam
is split into two different energy spectra that differ in table feel
direction (Siemens); and (4) a dual-layer detector with simul-
taneous data acquisition of the low- and high-energy dataset
(Phillips) [6, 18, 19].
To date, there are only two published review articles that
describe the application of DECT in cerebral or cerebrovas-
cular diseases from 2015 and 2016 [18, 20] and one on emer-
gency neuroimaging from 2016 [21]. Recently published
studies on the application of DECT in acute ischemic stroke
have not yet been recapitulated. The aim of this literature
review is to provide an overview of the clinical state-of-the-
art of this rapidly evolving technology.
Methods
A comprehensive search strategy was developed combining
the following major themes: “Dual-energy computed tomog-
raphy” AND “acute ischemic stroke.” PubMED and
EMBASE were separately searched using the following
terms: “Dual Energy Computed Tomography” or “Dual
Energy CT.” To this first screening we added either
“Haemorrhage” or “Ischemia” or “Infarction.” All studies
available in the English language were included, regardless
of the publication date, through 5 July 2020.
After excluding papers focused on other medical con-
ditions, case reports, animal model studies, or biomolec-
ular markers, and, after a cross-reference analysis, we
identified 25 pertinent studies that satisfied our inclusion
criteria (19 DECT applications in acute ischemic stroke,
and additional six for limitations of DECT applicability).
We added another 34 articles for background information
(25), comparison to alternative approaches (4), and future
outlook (5).
Clinical background
With routinely performed SECT “brain window” (BW)
series, early signs of cerebral infarctions can be visualized
between 3 and 6 h after onset [22, 23]. Following
endovascular (EST) or intravenous stroke therapy, techni-
cal success needs to be assessed to determine patient out-
come. With EST becoming the standard therapy in large-
vessel occlusions, further requirements for post-
interventional imaging have emerged. A disruption of
the blood-brain barrier (BBB) may lead to either hemor-
rhage or contrast staining following intra-arterial contrast
agent (CA) administration, both of which are challenging
to differentiate on SECT BW scans [18].
Furthermore, the detection of residual arterial clots or
early arterial re-thrombosis after EST in follow-up scans
is of the utmost interest for further treatment decisions.
However, clots might not be visible with SECT BW im-
aging or CT angiography following CA administration.
While many of the abovementioned imaging challenges
could be mastered with MR imaging, MRI scans are more
time-consuming, sometimes not available, and their appli-
cability hampered by patient-related contraindications
such as claustrophobia. Consequently, “optimized” CT
imaging for acute ischemic stroke in emergency settings
is urgently needed for treatment decision and prognostic
determination.
DECT further allows dose reduction, which, due to the
non-negligible radiation exposure of patients, has recently be-
come a critical concern.
However, CT perfusion (CTP) and CT angiography (CTA)
are also described to be accurate in detecting acute ischemic
stroke [24, 25] and, therefore, a comparison between one-stop
CTP/CTA and DECT is needed.
We performed literature research, which focused on
studies that applied DECT for the imaging (i) of acute
ischemic stroke, (ii) after EST, and (iii) of acute cerebral
arterial clots.
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Differentiation between hemorrhage
and iodine staining
In a phantom study with increasing hematocrit (5–85%) to
model hemorrhage, virtual non-contrast (VNC) attenuation
of spectral detector CT differentiated accurately between
blood and iodinated contrast mixtures in contrast to conven-
tional image attenuation [26].
Most clinical studies on the application of DECT in ische-
mic stroke investigated the differentiation between hemor-
rhage and iodine contrast staining due to BBB disruption,
especially after EST. While iodine map series (IM) depict
contrast-enhancing areas, VNC represents “unenhanced” im-
aging (Fig. 1).
The evaluation of VNC and IM series of 14 patients
allowed the differentiation between hemorrhage and contrast
enhancement with an accuracy of at least 91% in 28
hyperdense areas, as confirmed on follow-up scans [27]. In
40 patients, 148 hyperdense areas were investigated and cor-
rectly classifiedwith 100% sensitivity, 84.4–100% specificity,
and 87.2–100% diagnostic accuracy [28]. In 19 patients, VNC
and IM series achieved an 89% accuracy in comparison to
BW series, with 63% [29]. Hyperdense areas of 48 patients
after EST were assigned to contrast-enhancement or hemor-
rhage with no false-positives or false-negatives [30]. A reli-
able distinction was achieved throughout using 80- and 140-
kV tube voltage DECT. However, patient numbers are fairly
low given the increasing performance of EST worldwide.
Therefore, studies on larger cohorts with subjective and ob-
jective rating scales are needed to ultimately confirm the high
accuracy of DECT.
Hemorrhage and contrast enhancement might, however,
not be the only cause for hyperdense areas.
The diagnostic quality regarding intraparenchymal hemor-
rhage (IPH) and hypodense parenchymal lesions (HPL) of 58
patients with conventional image (CI) and virtual
monoenergetic image (VMI) reconstructions, ranging from
40 to 120 keV from dual-layer detector CT (DLCT), were
objectively assessed by ROI-based measurements, contrast-
to-noise ratio (CNR) calculation, and a 5-point Likert scale.
The improved depiction of HPL and IPH on VMI was greatly
dependent on the type of pathology and its location.
Fig. 1 Brain window (a, d), virtual non-contrast (b, e), and iodine map
(c, f) series. The upper row shows a hyperdense area in the left basal
ganglia on the brain window and iodine map, but not in the virtual
non-contrast series, representing contrast staining; the lower row
shows a hyperdense area in the right insular cortex of the brain win-
dow and the iodine map series, which is only partly hyperdense in the
virtual non-contrast series (arrow), representing both contrast staining
and hemorrhage
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Hypodense lesions in white matter (WM) and hyperdense
lesions in the gray matter (GM) were better visualized at
higher/120 keV, while hyperdense lesions in the WM and
hypodense lesions in the GM were better visualized at low/
40 keV [31].
A recent meta-analysis of DECT demonstrated excellent
diagnostic performance in terms of differentiating acute ICH
from contrast staining and small calcifications. However, it
was suggested that publication bias may lead to overestima-
tion of diagnostic performance, warranting large-scale, pro-
spective cohort studies [32].
Imaging of acute stroke
The second most emphasized improvement of DECT is visu-
alization of acute cerebral infarctions or hemorrhagic infarc-
tions with prior contrast application.
“Non-contrast-weighted sum images” resembling BW and
VNC imaging in a series of 58 patients after EST of the middle
cerebral artery (MCA), 24 h prior to DECT (80/140 kV) scans,
achieved an improved detection of infarction with VNC im-
aging compared to BW imaging, based on the ASPECTS
score, despite moderate inter-rater concordance [1, 2]. For
28 patients with acute cerebral infarction, “true non-contrast”
(resembling a BW series), VNC, “brain edema” (BE), and a
24-h follow-up series were reconstructed with 90-/150-kV
DECT within 4 h after onset and classified by the
ASPECTS score, with good inter-rater reliability. The BE
series was reconstructed by changing the relative dual-
energy contrast value according to the ratio of density differ-
ences between GM and WM on the 90-/150-kV series. The
BE imaging could detect brain edema and predict future in-
farction volumes more accurately than the BW or the VNC
series [3]. A so-called X-map was reconstructed from 80-/
150-kV DECT scans of six patients within 20 h after stroke
onset by changing the parameters of the DE “bone marrow”
application. The X-map focused on the mean densities of the
GM and the WM, and was then subjectively compared to a
“simulated standard CT” and follow-up diffusion-weighted
magnetic resonance imaging (DWI-MRI) series. All ischemic
lesions were detected with X-maps, and none was detected on
the BW series [4]. In a continuative study on 80-/150-kV
DECT in 11 patients, iterative beam-hardening correction
and settings in the “bone-marrow” application were modified
to achieve improved suppression of GM/WM contrast. This
advanced “X-map 2.0” allowed improved correlation with
infarction extent on DWI [33].
In a study of 100-/140-kV DECT scans immediately after
EST in 46 patients, the DE software settings were changed to
focus on mean densities of infarction/brain rather than
hemorrhage/iodine contrast by inserting mean densities of in-
farctions instead of hemorrhage on the 100- and 140-kV
series. In addition, relative dual-energy contrast was adapted
according to the mean density decrease of non-infarcted brain
tissue from the 100–140-kV VNC series. Tissue contrast was
determined quantitatively by contralateral-to-infarction ROI
density measurements, with high inter-rater reliability.
Infarction volumes were measured on three DECT series
and follow-up imaging. The highest cortex-to-infarction con-
trast and the best prediction of future infarct size were
achieved with EM compared to BW and VNC (Fig. 2). The
infarction location did not affect the detection rate [34].
Better image quality was achieved on 80- and 100-keV
extrapolated, monoenergetic series from DECT scans of 30
patients with early posterior fossa infarctions compared to
SECT and there was a trend toward a better infarction detect-
ability on the 100-kV series [5].
Compared to SECT, different DECT techniques can, there-
fore, improve the detection of early infarction.
However, while X-maps yield promising results, some
problems may result in false-positive or false-negative find-
ings. DECT images bear smearing artifacts near the brain–
skull boundary, and X-map values present large inter-patient
and intra-patient variations, especially with regard to the GM.
Some authors argue that X-maps cannot replace the simulated
standard CT for the diagnosis of acute ischemic stroke [4, 35].
In addition, patients with symptom onset up to 24 h before
CT were examined [2, 4], at a time point in which infarctions
could be depicted with BW. Furthermore, objective measure-
ments were not applied in some studies. Instead, subjective
rating scales were assessed [2–5, 33]. Some studies feature
small patient numbers [4, 33]. However, none of the studies
in EST patients provided thrombolysis in cerebral infarction
(TICI) scores prior to or after therapy, for reasons which re-
main unknown. Therefore, it is unclear whether the absence of
this score should be interpreted as a marker of technical ther-
apy success, or as a study limitation.
In a study on simulated conventional CT images after EST,
the Hounsfield unit (HU) values with IPH on VNC were sig-
nificantly higher than in its absence (cutoff 80 HU), and HU
values in the presence of delayed IPH were substantially
higher than without it (cutoff 78 HU) [36].
VMI monochromatic 99-keV images yielded the best bal-
ance between infarction and normal brain parenchyma for the
evaluation of acute MCA brain infarction and were not infe-
rior to 70-keV images [37].
Prediction of infarction development
or future hemorrhagic transformation
in contrast-enhancing areas
Contrast-enhancing areas on DECT (100/140 kV) immediate-
ly after EST in 132 patients were found in 32 and hemorrhage
in 53 patients. Follow-up imaging was either CT or MR
4141Eur Radiol  (2021) 31:4138–4147
imaging. Subjective assessment by an uncertain amount of
raters revealed both contrast enhancement (odds ratio (OR)
11.3) and hemorrhage (OR 10.4) to be associated with a poor
clinical outcome (modified Rankin scale 3–6), even if com-
plete recanalization was achieved. In addition, patients with
contrast-enhancing areas displayed a higher rate of delayed
hemorrhagic transformations (OR 4.5) [38]. To investigate
under which circumstances contrast-enhancing areas would
transform to infarctions or delayed hemorrhage, the DECT
scans (100/140 kV) of 20 patients with 44 contrast-
enhancing areas who underwent EST were analyzed and
ROI density measurements were performed on BW, VNC,
and IM imaging by two raters, withhigh inter-rater reliability.
Areas that transformed to infarctions revealed higher densities
on IM, representing a higher amount of contrast enhancement
(Fig. 3), with a cutoff value of 34.1 HU, compared to areas
that did not transform (area under the curve (AUC) 0.99). For
the prediction of delayed hemorrhage, the AUCwas 0.78 [39].
On the DECT (80/140 kV) images of 85 patients immediately
after EST, maximum iodine concentration was measured by
two raters, if iodine stainingwas present (n = 54). In areas with
an iodine concentration > 1.35 mg/dl, later development of
hemorrhage was more likely, with an AUC of 0.89 [40].
These studies suggest that the presence or amount of con-
trast staining after EST may have predictive value for the
clinical outcome. However, in some studies, clinical parame-
ters were not considered and follow-up imaging was inconsis-
tent with regard to time interval and imaging method [38–40].
Clot imaging
DECT may be beneficial for the visualization of intracranial
arteries with clot material after prior contrast administration,
compared to SECT. In the first in vivo study, it was concluded
that an additional BW may be omitted. As with the VNC
reconstructions from CT angiography, hyperdense arteries
can be detected; however, no evaluation of the VNC with
regard to the detection of early infarctions was performed,
which is at least equally important in the acute stages [41].
In the second in vivo study, there was no comparison of arter-
ies with residual clot material to the “gold-standard,” TICI
scoring (thrombolysis in cerebral infarction), although con-
ventional angiography studies were available [42]. The results
about clot composition of artificial clots have yet to be verified
in vivo [43, 44].
Fig. 2 Brain window (a, e), virtual non-contrast (b, f), edema map (c, g),
and follow-up (d, h) brain window series. The upper row shows no
infarction demarcation in the brain window or the virtual non-contrast
series, but a clear demarcation on the edemamap (arrows), corresponding
to the follow-up series; the lower row shows only a slight infarction
demarcation in the left basal ganglia on the brain window and the virtual
non-contrast series, but a clear demarcation on the edema map (arrows),
corresponding to the follow-up series
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DECT can be applied to differentiate intra-arterial CA
from clots. To date, in vivo studies about the detection of
intracranial arterial clots are sparse.
Intra-arterial clot detection on a VNC series recon-
structed from DECT (80/140 kV) angiography was equal
to that on a BW/true non-contrast series in 30 patients
with stroke and hyperdense-artery signs and 30 controls.
That series achieved a 93% accuracy upon application of
a subjective rating scale and objective ROI density mea-
surements within arteries with clot material, contralateral
arteries without clot material, and the arteries of controls
[41].
In 10/16 patients with EST of large intracranial arteries and
immediate post-interventional DECTs (100/140 kV), residual
peripheral clots were found on the digital angiography series
on the BW, VNC, and IM protocols. Arteries with clot mate-
rial were identified in 9/10 cases on the VNC only, while the
absence of clots was correctly rated in 5/6. Arteries with clot
material were significantly denser than perfused arteries on the
VNC only (Fig. 4) [42].
DECT in the context of CTA and CTP
To date, comparative studies between DECT and CTP or
CTA technology regarding the abovementioned advan-
tages of DECT compared to conventional CT and MRI
in the application of acute ischemic stroke remain sparse.
CTA provides the treating physician of patients who
present with acute ischemic stroke with advantages that
help in clinical decision-making, such as detailing the
presence of occlusion, the extent of thrombus, and
neurovascular anatomy [45], with known drawbacks, in-
cluding radiation, risk of contrast-induced nephropathy,
and the time required to perform a CTA [45].
One advancement in this field is one-stop CTP/CTA tech-
nology, which has been widely used in clinical diagnosis and
prognostic evaluation of patients with cerebral ischemic stroke.
Especially in an emergency situation, apart from demarcating
the ischemic phase and range, one-stop CTP/CTA technology
can also determine the location and range of embolus and, there-
fore, assist with clinical diagnosis and treatment.
Fig. 3 Brain window (a, d), iodine map (b, e), and diffusion-weighted
follow-up MRI (c, f) series. The upper row shows a slight iodine staining
in both thalami and the right occipital lobe on the brain window and the
iodine map series, with no future infarction; the lower row shows more
pronounced iodine staining in both thalami and the right upper cerebel-
lum, with later infarction development
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Collateral status, as assessed with different scoring sys-
tems, is an important factor that determines outcome in acute
ischemic stroke. Upon the application of single- and multi-
phase CTA (spCTA and mpCTA) and compared to CTP pa-
rameters, collateral status evaluated on spCTA was shown to
suffice for outcome prediction and decision-making in pa-
tients with ischemic stroke, potentially obviating further im-
aging modalities like mpCTA or CTP [25].
Despite little evidence, CTP might be more accurate than
NCCT with an accuracy similar to that of CTA in detecting
acute ischemic stroke, thus demonstrating a potential treat-
ment benefit of CTP in select stroke patients [24].
Novel 4D CTA scan protocol has been introduced, includ-
ing a non-enhanced CT, dynamic CTA with reconstructed
arterial and venous phases, perfusion of the whole brain, and
CTA of the carotid arteries in a single acquisition using a 320-
row area detector CT scanner. This approach involves a
unique contrast injection technique and an acceptable radia-
tion exposure dose in patients who present with acute ische-
mic stroke, and also uses model-based iterative reconstruction
(MBIR), time summing reconstructions (time-maximum-in-
tensity projection, tMIP), and subtraction techniques to opti-
mize the results [46].
CTA is also used to determine a potential thrombus residue
after thrombectomy, which is significant for the clinical out-
come [47], as re-occlusion is more common in cases with
residual thrombus [48].
DECT is valuable in the detection of clot persistence or
early re-thrombosis without the necessity for additional con-
trast administration, but its relevance for the prediction of
outcomes remains to be determined in further studies [42].
Further studies are needed to compare the value of DECT
and CTA, as well as CTP.
Future aspects
A newly developed technique, multi-energy CT (MECT), em-
ploys novel photon-counting detectors in an image-based ma-
terial decomposition task.
Photon-counting detector models withmultiple energy bins
achieve a performance comparable to DECT at 100 kV/Sn
140 kV. With the use of photon-counting detectors in dual-
source protocols, however, the performance can be improved
above the level of a single, realistic photon-counting detector
and also dual-source DECT [15].
Greater GM/WM differentiation, compared to convention-
al CT, with excellent intra-reader and inter-rater reproducibil-
ity, was achieved, which was linked to higher soft tissue con-
trast and 12.8–20.6% less image noise [15].
A spectral photon-counting detector (PCD) CT for the
evaluation of the major arteries of the head and neck achieved
significantly higher image quality scores with lower image
noise and fewer image artifacts compared to conventional
single-energy CT scans using energy-integrating detectors
(EID).
Intra-arterial artifacts on EID images were not depicted on
PCD images due to beam hardening. Iodine maps achieved a
20.7% higher CNR compared to non-spectral PCD, and VMI
at 70 keV provided CNR similar to that of non-spectral im-
ages. Consequently, photon-counting CT might potentially
improve the image quality of carotid and intracranial CT an-
giography compared to single-energy EID CT [49].
A recently proposed new method is to extract the effective
atomic number (Zeff) and electron density (ρe) from DECT
images based on a Karhunen-Loeve expansion (KLE) of the
atomic cross-section per electron. An effective atomic number
map provides, therefore, a quantitative approach to material
Fig. 4 Conventional angiography (a), brain window (b), and virtual non-
contrast (c). A residual clot of the M2 part of the right middle cerebral
artery known from the final angiography series after thrombectomy, seen
as hyperdense dots on the brain window and the virtual non-contrast
series (circles)
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differentiation by analyzing attenuation changes as a function
of energy [6, 50]. This approach has already found clinical
applications, such as the advanced detection of lung perfusion
defects caused by pulmonary embolism on an effective atomic
number map compared to an iodine map [6]. Another neuro-
radiological application is the prediction of brain tumor his-
tology, where intracranial neoplasms were found to be sepa-
rated into three major groups: gliomas, meningiomas, and
metastases [51]. The useful value of z-maps appears to be
the percentage change in the effective atomic number follow-
ing contrast enhancement [52]. Potentially, the calculated ef-
fective atomic number of tissue in every voxel might also be
useful for clot differentiation. Further studies are required to
investigate the potential of this approach in the workup of
acute ischemic stroke.
Despite the benefits of DECT for material differentiation,
material decomposition suffers from magnified noise from
two CT images of two separate scans, potentially leading to
degradation of image quality. This might be due to the fact
that implemented algorithms exhibit suboptimal decomposi-
tion performance, which fail to fully depict the mapping rela-
tionship between DECT images and basic materials, especial-
ly under noisy conditions. Improvements are expected from
techniques such as iterative reconstruction to enhance image
quality and artificial intelligence, which will likely boost ma-
terial decomposition. Convolutional neural networks have re-
cently become an important technique in medical imaging,
including modeling of data coupling to perform image domain
material decomposition for DECT. The proposed approach
was shown to lead to higher decomposition quality in noise
suppression on clinical datasets compared to those using con-
ventional schemes [53].
Limitations
Given the different technical approaches of DECT imaging as
provided by different companies, imaging data may differ
marginally and hamper their comparability in clinical applica-
tions. Hence, the results of the studies reported in the present
review may not be repeatable with different scanner types and
different scanner generations [53, 54]. Large multi-center
studies would be needed that would include different scanners
to confirm whether the achieved results are applicable when
using alternative techniques. However, some findings have
been validated multiple times in different studies even with
different scanning techniques, thus emphasizing the robust-
ness of the DECT method.
While DECT material decomposition is usually successful
in neuroradiology, a major limitation is that the distinction is
limited to up to three preselected materials.
Using a three-material decomposition algorithm to obtain
VNC and iodine (or calcium) overlay images, DECT was
successfully used in 90.2% of 72 cases for the differentiation
of CA staining and/or extravasation from IPH, calcium from
IPH, and for metal-artifact reduction and angiographic assess-
ment. However, a fourth material, for example, parenchymal
calcifications, may confound the analysis. Material decompo-
sition is further impaired by artifacts, such as beam hardening,
metallic streak, or saturation effects [55].
The presented studies, however, provide an important hint
for possible future applications of DECT, and about how the
latest CT technologies may change our daily diagnoses to
achieve more accurate results.
While this review is not intended to assess the various
scanner technologies and imaging methods, Table 1 provides
an overview of which scanner technology achieved specific
research advancements by describing technical terms with ki-
lovolt pair settings.
Third-generation dual-energy scanners outperform earlier
generations and ongoing improvements may be expected [53,
54, 56–58]. Standardization of methods will allow compara-
ble imaging between different centers.
Table 1 Overview of the different scanner technologies (described by








80/140 kV Gupta et al (2010) [27],
Phan et al (2012) [28],
Tijssen et al (2014) [29],
Morhard et al (2014) [30]
Acute stroke 80/140 kV Gariani et al (2015) [36]
90/150 kV Mohammed et al (2018) [3]
80/150 kV Noguchi et al (2017) [4],
Taguchi et al (2018) [33]
100/140 kV Grams et al (2018) [34]







100/140 kV Renu et al (2015) [39],
Djurdjevic et al (2017) [40]
80/140 kV Bonatti et al (2018) [41]
Clot imaging 80/140 kV Winklhofer et al (2017) [44],
Brinjikji et al (2017) [42]
100/140 kV Grams et al (2015) [45],





Borggrefe et al (2017) [43]
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Conclusion
The currently most intriguing clinical application of DECT in
stroke patients is the differentiation between hemorrhage and
contrast staining after prior iodine contrast application and
arterial clots can be reliably visualized with a VNC series after
iodine contrast administration.
Future research should focus on potential differences relat-
ed to technically varying DECT imaging approaches between
vendors. Candidates for clinical implementation in the near
future are MECT, PCD, effective atomic number and electron
density Zeff, and artificial intelligence.
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